Skip to content

Prospective, single-arm, study on the usefulness of blood flow evaluation of gastric tube and remnant esophagus using the SPY-QP software system in minimally invasive esophagectomy for esophageal cancer

Prospective, single-arm, study on the usefulness of blood flow evaluation of gastric tube and remnant esophagus using the SPY-QP software system in minimally invasive esophagectomy for esophageal cancer - Prospective, single-arm, study on the usefulness of blood flow evaluation of gastric tube and remnant esophagus using the SPY-QP software system in minimally invasive esophagectomy for esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057825
Enrollment
90
Registered
2025-05-12
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Visualisation of the fluorescence excited by indocyanine green in the gastric tube and remnant esophageal wall using a Stryker video processor with integrated light source and SPY PHI, and quantitativ

Sponsors

Kobe University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The patient has a histological diagnosis of esophageal squamous cell carcinoma. 2) The planned operative procedure is a right thoracic approach subtotal esophagectomy and gastric tube reconstruction. 3) The patient is at least 18 years of age on the date of registration. 4) Gender is not relevant. 5) PS is 0 or 1 according to ECOG criteria. 6) Latest laboratory values within 28 days prior to enrolment are all below. Neutrophil count > 1,500/mm3 Platelet count > 7.5 x 104 /mm3 Hemoglobin > 9.0 g/dL Creatinine: < 1.5 times upper limit of normal AST/ALT: < 3 times upper limit of normal Total bilirubin: normal Less than 1.5 times the upper limit (for Gilbert's syndrome: Less than 3.0 mg/dL) 7)The patient's free written consent to participate in this clinical study has been obtained.

Exclusion criteria

Exclusion criteria: 1) Has an allergy to iodine or indocyanine green. 2) Have active systemic infections. 3) Requires treatment with systemic corticosteroids (prednisone equivalent >10 mg/day: inhaled and topical steroids and hormone replacement therapy are acceptable) or other immunosuppressive agents. 4) Planned two-stage surgery. 5) The patient is unwilling to use contraception and is pregnant or lactating. 6) Patients with dementia or psychiatric disorders requiring treatment that make it difficult to obtain their consent. 7) Other patients who are deemed inappropriate by the person in charge of this clinical research.

Design outcomes

Primary

MeasureTime frame
Rate of anastomotic leakage

Countries

Japan

Contacts

Public ContactHironobu Goto

Kobe University Hospital Division of Gastrointestinal Surgery

ichige@med.kobe-u.ac.jp0783825925

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026